Week 6 document outlines the identification and validation of specialty drugs in Medicare and Medicaid spending datasets from 2018 to 2022. 
The analysis involved loading the dataset into Pandas, standardizing drug names, and applying fuzzy string matching for accurate classification. 
High-cost thresholds and specialty pharmacy criteria were used to define specialty drugs. 
The identified drugs were validated against authoritative sources like CVS Specialty Pharmacy. 
A final CSV listing the top 50 specialty drugs by spending was generated. 
All identified drugs were confirmed as specialty medications, ensuring a reliable foundation for further cost analysis and policy recommendations.

